Low Birth Weight Fetuses With Caffeine Use

NCT ID: NCT03757780

Last Updated: 2019-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-30

Study Completion Date

2019-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Globally, it has been estimated that 15.5% of all infantsare born low birth weight, defined as birthweight less than 2,500 g .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Low birth weight is not only associated with neonatal mortality and morbidity.

but also with a higher risk of chronic diseases such as type 2 diabetes and cardiovascular diseases in adult life

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low; Birthweight, Extremely (999 Grams or Less)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant ladies who are caffeine using

ladies who uses caffeine during pregnancy

Questionaire

Intervention Type OTHER

A questionaire will be made to pregnant ladies who take caffeine during pregnancy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionaire

A questionaire will be made to pregnant ladies who take caffeine during pregnancy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age group: 18-40
* Pregnant females attending regular post-natal care visits

Exclusion Criteria

* • Female patients with other acute or chronic illness

* Cardiovascular disease
* Neoplasms
* Current diabetes mellitus, pregnancy induced diabetes
* Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role collaborator

Aljazeera Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahmoud Alalfy

Role: STUDY_CHAIR

Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Algazeerah and Kasralainy hospital

Giza, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmoud Alalfy

Role: CONTACT

01002611058

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mahmoud Alalfy, master

Role: primary

+201002611058

Ahmed Elgazzar, M.D

Role: backup

+201014005959

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

low birth weight

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NAS Treatment - Opiate Versus Non-Opiate
NCT01734551 COMPLETED PHASE4